Kayne Anderson Rudnick Investment Management’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16
Closed -$1K 628
2022
Q1
$1K Buy
+16
New +$1K ﹤0.01% 628